Document Detail


Induction of apoptosis by esculetin in human leukemia cells.
MedLine Citation:
PMID:  11282109     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Esculetin, a coumarin compound, has been shown to exhibit antioxidant and anti-inflammatory effects. In the present study, esculetin was found to inhibit the survival of human promyelocytic leukemia HL-60 cells in a concentration-dependent and time-dependent manner. HL-60 cells underwent internucleosomal DNA fragmentation and morphological changes characteristic of apoptosis after a 24-h treatment with esculetin (100 microM). Flow cytometric analysis showed that the hypodiploid nuclei of HL-60 cells were increased to 40.93% after a 36-h treatment with esculetin (100 microM). Further investigation showed that esculetin induced the release of cytochrome c from mitochondria into cytosol in a time-dependent and concentration-dependent manner. Moreover, esculetin application reduced Bcl-2 protein expression to 58% after 9 h as compared with that time at 0. Cysteine protease 32 kDa proenzyme (CPP32), a caspase 3, was activated and its substrate, poly (adenosine diphosphate-ribose) polymerase, was cleaved after a 24-h treatment of HL-60 cells with esculetin. These data suggest that esculetin induces apoptosis in human leukemia cells by increasing cytosolic translocation of cytochrome c and activation of CPP32.
Authors:
C Y Chu; Y Y Tsai; C J Wang; W L Lin; T H Tseng
Related Documents :
10082299 - Analysis of apoptosis by laser scanning cytometry.
19368349 - Evaluation of antiproliferative activities and action mechanisms of extracts from two s...
17065379 - Cell death, remodeling, and repair in chronic obstructive pulmonary disease?
18804099 - Differential sensitivity of human glioblastoma ln18 (pten-positive) and a172 (pten-nega...
15099759 - Flow cytometric evaluation of a model for phagocytosis of cells undergoing apoptosis.
9879459 - Video-enhanced microscopic visualization of apoptotic cell death caused by anti-fas ant...
21209109 - Complex cell cycle abnormalities caused by human t-lymphotropic virus type 1 tax.
9071229 - Clonal analysis of the in vivo differentiation potential of keratinocytes.
24153179 - Differential l1 regulation in pluripotent stem cells of humans and apes.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of pharmacology     Volume:  416     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-04-03     Completed Date:  2001-07-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  25-32     Citation Subset:  IM    
Affiliation:
Department and Institute of Biochemistry, Chung Shan Medical and Dental College, No. 110, Section 1, Chien Kuo N. Road, 402, Taichung, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antioxidants / pharmacology*
Apoptosis / drug effects*
Caspase 3
Caspases / drug effects,  metabolism
Cell Survival / drug effects
Cytochrome c Group / drug effects,  metabolism
DNA Fragmentation / drug effects
Dose-Response Relationship, Drug
HL-60 Cells / cytology,  drug effects,  metabolism
Humans
Poly(ADP-ribose) Polymerases / drug effects,  metabolism
Proto-Oncogene Proteins c-bcl-2 / drug effects,  metabolism
Time Factors
Umbelliferones / pharmacology*
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Cytochrome c Group; 0/Proto-Oncogene Proteins c-bcl-2; 0/Umbelliferones; 305-01-1/esculetin; EC 2.4.2.30/Poly(ADP-ribose) Polymerases; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells...
Next Document:  Ligand induced conformational states of the 5-HT(1A) receptor.